Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The company announced positive topline data from the Phase 3 ADorable-1 trial
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
The study met its primary endpoint with flying colors
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
Subscribe To Our Newsletter & Stay Updated
